Dutasteride; Tamsulosin Hydrochloride is used for treating benign prostatic hyperplasia and other androgen responsive or mediated conditions in mammals with Dutasteride. It was first introduced by Waylis Therapeutics Llc in its drug Jalyn on Jun 14, 2010. 5 different companies have introduced drugs containing Dutasteride; Tamsulosin Hydrochloride.

Dutasteride; Tamsulosin Hydrochloride Patents

Given below is the list of patents protecting Dutasteride; Tamsulosin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Jalyn	US5565467	Androstenone derivative	Nov 20, 2015 (Expired)	Waylis Therap
Jalyn	US5846976	Androstenone derivative	Sep 17, 2013 (Expired)	Waylis Therap
Jalyn	US5998427	Androstenones	Sep 17, 2013 (Expired)	Waylis Therap

Add above patents to watchlist

Dutasteride; Tamsulosin Hydrochloride's Family Patents

Full family tree

Dutasteride; Tamsulosin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Dutasteride; Tamsulosin Hydrochloride. The first generic version for Dutasteride; Tamsulosin Hydrochloride was by Ph Health Ltd and was approved on Feb 26, 2014. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jul 18, 2024.

Given below is the list of companies who have filed for Dutasteride; Tamsulosin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.